An 18-fluorodeoxyglucose-PET study in SGCE positive and negative myoclonus-dystonia
Brain Communications · 05.05.2026 · 8 (3)
DOI: 10.1093/braincomms/fcag131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 06.05.2026. Verfasst von Elze R Timmers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Myoclonus-dystonia is a hyperkinetic movement disorder, and approximately half of myoclonus-dystonia patients have a mutation in the epsilon-sarcoglycan (SGCE) gene, while the remaining cases often have undetermined causative genes. This study aims to assess brain metabolic function in myoclonus-dystonia patients with and without SGCE mutations and compare them with a control group. This study is part of the Next Move in Movement Disorders observational study. We included 23 myoclonus-dystonia patients (11 with SGCE mutations and 12 without) and 23 age-matched controls. Participants underwent 18-fluordeoxyglucose-PET and anatomical MRI scans. Data were analysed using a voxel-based analysis and a volume of interest (VOI)–based analysis. In the voxel-based analyses, trends towards differences in the supplementary motor area, cingulate gyrus, parietal and occipital lobe were found. When comparing mutation-positive with mutation-negative patients, trends towards differences in the parietal lobe and pre-central gyrus were detected. Symptom severity was correlated with changed metabolism in post-central and supramarginal gyrus, occipital and frontal lobe, cerebellum and caudate nucleus. In addition, VOI-based analyses showed statistically significant differences in the supplementary motor area comparing myoclonus-dystonia patients with controls. The identified trends of increased metabolism in the (pre)motor cortex areas fit the model of a more ‘excitable’ state with a lower activation threshold, possibly due to reduced inhibition from the cerebellum and striatum, regions in which we found a negative correlation between symptom severity and metabolism. Differences were also observed in sensory areas such as the parietal lobe and visual cortex. While the phenotype of SGCE mutation-positive and mutation-negative groups is similar, subtle differences suggest distinct endophenotypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.
- Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), Groningen, Groningen 9713 GZ, The Netherlands.
- Clinical Neuroimaging HUG, Hopitaux Universitaires de Genève, 1211 Genève, Switzerland.
ORCID-Profile: Henriëtte C J Dijkhuis, Bauke M de Jong, Débora E Peretti, Jelle R Dalenberg, Marina A J Tijssen
Förderung
- ZonMw
Zitieren
APA
Timmers, E. R., Dijkhuis, H. C. J., Marapin, R. S., de Jong, B. M., Peretti, D. E., Dalenberg, J. R., & Tijssen, M. A. J. (2026). An 18-fluorodeoxyglucose-PET study in SGCE positive and negative myoclonus-dystonia. Brain Communications, 8(3). https://doi.org/10.1093/braincomms/fcag131
Vancouver
Timmers ER, Dijkhuis HCJ, Marapin RS, de Jong BM, Peretti DE, Dalenberg JR, et al. An 18-fluorodeoxyglucose-PET study in SGCE positive and negative myoclonus-dystonia. Brain Communications. 2026;8(3). doi:10.1093/braincomms/fcag131
BibTeX
@article{Timmers2026,
author = {Timmers, Elze R and Dijkhuis, Henriëtte C J and Marapin, Ramesh S and de Jong, Bauke M and Peretti, Débora E and Dalenberg, Jelle R and Tijssen, Marina A J},
title = {An 18-fluorodeoxyglucose-PET study in SGCE positive and negative myoclonus-dystonia},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {3},
doi = {10.1093/braincomms/fcag131}
}
EUVIMED